Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Sumant Kulkarni is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | CRVO | Buy Now | CervoMed | $9.00 | 133.33% | Sumant Kulkarni42% | $12 → $21 | Maintains | Buy | Get Alert |
| 03/13/2025 | ZVRA | Buy Now | Zevra Therapeutics | $7.97 | 213.68% | Sumant Kulkarni42% | $23 → $25 | Maintains | Buy | Get Alert |
| 03/13/2025 | VYGR | Buy Now | Voyager Therapeutics | $3.88 | 208.88% | Sumant Kulkarni42% | $14 → $12 | Maintains | Buy | Get Alert |
| 02/28/2025 | CMPS | Buy Now | Compass Pathways | $3.26 | 360.12% | Sumant Kulkarni42% | $23 → $15 | Maintains | Buy | Get Alert |
| 02/13/2025 | BIIB | Buy Now | Biogen | $143.09 | 85.2% | Sumant Kulkarni42% | $298 → $265 | Maintains | Buy | Get Alert |
| 02/12/2025 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 2.04% | Sumant Kulkarni42% | $9 → $8 | Maintains | Hold | Get Alert |
| 02/12/2025 | CYBN | Buy Now | Cybin | — | — | Sumant Kulkarni42% | $86 → $73 | Maintains | Buy | Get Alert |
| 02/07/2025 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 52.04% | Sumant Kulkarni42% | $172 → $163 | Maintains | Buy | Get Alert |
| 01/31/2025 | ITCI | Buy Now | Intra-Cellular Therapies | $131.41 | 0.45% | Sumant Kulkarni42% | $119 → $132 | Downgrade | Buy → Hold | Get Alert |
| 01/06/2025 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 112.77% | Sumant Kulkarni42% | $112 → $80 | Maintains | Buy | Get Alert |
| 12/11/2024 | CRVO | Buy Now | CervoMed | $9.00 | 33.33% | Sumant Kulkarni42% | $65 → $12 | Maintains | Buy | Get Alert |
| 11/19/2024 | CYBN | Buy Now | Cybin | — | — | Sumant Kulkarni42% | $86 → $86 | Maintains | Buy | Get Alert |
| 11/18/2024 | GHRS | Buy Now | GH Research | $10.60 | 164.15% | Sumant Kulkarni42% | $31 → $28 | Maintains | Buy | Get Alert |
| 11/18/2024 | ATAI | Buy Now | ATAI Life Sciences | $1.40 | 685.71% | Sumant Kulkarni42% | $11 → $11 | Maintains | Buy | Get Alert |
| 11/14/2024 | ZVRA | Buy Now | Zevra Therapeutics | $7.97 | 188.58% | Sumant Kulkarni42% | $25 → $23 | Maintains | Buy | Get Alert |
| 11/14/2024 | VYGR | Buy Now | Voyager Therapeutics | $3.88 | 260.36% | Sumant Kulkarni42% | $14 → $14 | Maintains | Buy | Get Alert |
| 11/14/2024 | CYBN | Buy Now | Cybin | — | — | Sumant Kulkarni42% | $96 → $86 | Maintains | Buy | Get Alert |
| 11/14/2024 | CLNN | Buy Now | Clene | $4.35 | 1808.05% | Sumant Kulkarni42% | $86 → $83 | Maintains | Buy | Get Alert |
| 10/04/2024 | CLNN | Buy Now | Clene | $4.35 | 1877.01% | Sumant Kulkarni42% | $94 → $86 | Maintains | Buy | Get Alert |
| 09/23/2024 | CYBN | Buy Now | Cybin | — | — | Sumant Kulkarni42% | $114 → $96 | Maintains | Buy | Get Alert |
| 09/18/2024 | ZVRA | Buy Now | Zevra Therapeutics | $7.97 | 176.04% | Sumant Kulkarni42% | $24 → $22 | Maintains | Buy | Get Alert |
| 09/16/2024 | MNMD | Buy Now | Mind Medicine | $6.40 | 118.74% | Sumant Kulkarni42% | $16 → $14 | Maintains | Buy | Get Alert |
| 08/30/2024 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 197.87% | Sumant Kulkarni42% | $112 → $112 | Maintains | Buy | Get Alert |
| 08/06/2024 | CLNN | Buy Now | Clene | $4.35 | 2060.92% | Sumant Kulkarni42% | $94 → $94 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2024 | CMPS | Buy Now | Compass Pathways | $3.26 | 1372.39% | Sumant Kulkarni42% | $50 → $48 | Maintains | Buy | Get Alert |
| 07/25/2024 | CRVO | Buy Now | CervoMed | $9.00 | 622.22% | Sumant Kulkarni42% | $65 → $65 | Maintains | Buy | Get Alert |
| 06/27/2024 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 197.87% | Sumant Kulkarni42% | $112 → $112 | Maintains | Buy | Get Alert |
| 06/20/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.41 | -14.01% | Sumant Kulkarni42% | $107 → $113 | Maintains | Buy | Get Alert |
| 06/13/2024 | CARA | Buy Now | Cara Therapeutics | $4.01 | -75.06% | Sumant Kulkarni42% | $120 → $12 | Downgrade | Buy → Hold | Get Alert |
| 05/07/2024 | STOK | Buy Now | Stoke Therapeutics | $9.30 | 115.05% | Sumant Kulkarni42% | $21 → $20 | Maintains | Buy | Get Alert |
| 05/06/2024 | GHRS | Buy Now | GH Research | $10.60 | 192.45% | Sumant Kulkarni42% | $30 → $31 | Maintains | Buy | Get Alert |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 52.97% | Sumant Kulkarni42% | $154 → $164 | Maintains | Buy | Get Alert |
| 04/30/2024 | ANVS | Buy Now | Annovis Bio | $1.81 | 1336.46% | Sumant Kulkarni42% | $36 → $26 | Maintains | Buy | Get Alert |
| 04/26/2024 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 116.84% | Sumant Kulkarni42% | $21 → $17 | Maintains | Hold | Get Alert |
| 04/23/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.41 | -18.58% | Sumant Kulkarni42% | $100 → $107 | Maintains | Buy | Get Alert |
| 04/08/2024 | CRVO | Buy Now | CervoMed | $9.00 | 622.22% | Sumant Kulkarni42% | $50 → $65 | Maintains | Buy | Get Alert |
| 03/26/2024 | STOK | Buy Now | Stoke Therapeutics | $9.30 | 125.81% | Sumant Kulkarni42% | $18 → $21 | Maintains | Buy | Get Alert |
| 03/14/2024 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 197.87% | Sumant Kulkarni42% | $288 → $112 | Maintains | Buy | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 83.33% | Sumant Kulkarni42% | $40 → $33 | Maintains | Buy | Get Alert |
| 03/06/2024 | CARA | Buy Now | Cara Therapeutics | $4.01 | 149.38% | Sumant Kulkarni42% | $132 → $120 | Maintains | Buy | Get Alert |
| 02/23/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.41 | -23.9% | Sumant Kulkarni42% | $101 → $100 | Maintains | Buy | Get Alert |
| 02/20/2024 | BIIB | Buy Now | Biogen | $143.09 | 113.15% | Sumant Kulkarni42% | $310 → $305 | Maintains | Buy | Get Alert |
| 02/15/2024 | CRVO | Buy Now | CervoMed | $9.00 | 455.56% | Sumant Kulkarni42% | → $50 | Initiates | → Buy | Get Alert |
| 12/29/2023 | ANVS | Buy Now | Annovis Bio | $1.81 | 1888.95% | Sumant Kulkarni42% | → $36 | Initiates | → Buy | Get Alert |
| 12/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 39.91% | Sumant Kulkarni42% | → $150 | Reiterates | Buy → Buy | Get Alert |
| 11/08/2023 | ZVRA | Buy Now | Zevra Therapeutics | $7.97 | 201.13% | Sumant Kulkarni42% | $20 → $24 | Maintains | Buy | Get Alert |
| 11/06/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 122.22% | Sumant Kulkarni42% | $38 → $40 | Maintains | Buy | Get Alert |
| 09/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 34.32% | Sumant Kulkarni42% | $132 → $144 | Maintains | Buy | Get Alert |
| 09/01/2023 | ZVRA | Buy Now | Zevra Therapeutics | $7.97 | 150.94% | Sumant Kulkarni42% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 09/01/2023 | CYBN | Buy Now | Cybin | — | — | Sumant Kulkarni42% | → $190 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | CMPS | Buy Now | Compass Pathways | $3.26 | 1433.74% | Sumant Kulkarni42% | $60 → $50 | Maintains | Buy | Get Alert |
| 08/16/2023 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | Sumant Kulkarni42% | $10 → $1.11 | Downgrade | Buy → Hold | Get Alert |
| 08/15/2023 | ZVRA | Buy Now | Zevra Therapeutics | $7.97 | 150.94% | Sumant Kulkarni42% | $19 → $20 | Maintains | Buy | Get Alert |
| 08/15/2023 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 751.06% | Sumant Kulkarni42% | $1216 → $320 | Maintains | Buy | Get Alert |
| 08/11/2023 | CYBN | Buy Now | Cybin | — | — | Sumant Kulkarni42% | $228 → $190 | Maintains | Buy | Get Alert |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 167.86% | Sumant Kulkarni42% | $64 → $21 | Downgrade | Buy → Hold | Get Alert |
| 08/03/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 111.11% | Sumant Kulkarni42% | $39 → $38 | Maintains | Buy | Get Alert |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 23.12% | Sumant Kulkarni42% | $130 → $132 | Maintains | Buy | Get Alert |
| 07/17/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 116.67% | Sumant Kulkarni42% | $28 → $39 | Maintains | Buy | Get Alert |
| 07/03/2023 | CYBN | Buy Now | Cybin | — | — | Sumant Kulkarni42% | $266 → $228 | Maintains | Buy | Get Alert |
| 06/12/2023 | BIIB | Buy Now | Biogen | $143.09 | 144.6% | Sumant Kulkarni42% | $330 → $350 | Maintains | Buy | Get Alert |
| 05/10/2023 | VYGR | Buy Now | Voyager Therapeutics | $3.88 | 260.36% | Sumant Kulkarni42% | $10 → $14 | Maintains | Buy | Get Alert |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 21.26% | Sumant Kulkarni42% | $132 → $130 | Maintains | Buy | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $143.09 | 130.62% | Sumant Kulkarni42% | $325 → $330 | Maintains | Buy | Get Alert |
| 04/26/2023 | STOK | Buy Now | Stoke Therapeutics | $9.30 | 158.06% | Sumant Kulkarni42% | → $24 | Assumes | → Buy | Get Alert |
| 03/30/2023 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 23.12% | Sumant Kulkarni42% | $124 → $132 | Upgrade | Hold → Buy | Get Alert |
| 03/29/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.41 | -25.42% | Sumant Kulkarni42% | $93 → $98 | Maintains | Buy | Get Alert |
| 03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 44.44% | Sumant Kulkarni42% | $24 → $26 | Maintains | Buy | Get Alert |
| 03/07/2023 | CARA | Buy Now | Cara Therapeutics | $4.01 | 523.44% | Sumant Kulkarni42% | $348 → $300 | Maintains | Buy | Get Alert |
| 11/11/2022 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 3134.04% | Sumant Kulkarni42% | $1200 → $1216 | Maintains | Buy | Get Alert |
| 10/04/2022 | CLNN | Buy Now | Clene | $4.35 | 37.93% | Sumant Kulkarni42% | $200 → $120 | Maintains | Buy | Get Alert |
| 09/15/2022 | KMPH | Buy Now | KemPharm | — | — | Sumant Kulkarni42% | → $20 | Initiates | → Buy | Get Alert |
| 06/23/2022 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | Sumant Kulkarni42% | $9 → $11 | Maintains | Buy | Get Alert |
| 05/02/2022 | CLNN | Buy Now | Clene | $4.35 | 129.89% | Sumant Kulkarni42% | → $200 | Initiates | → Buy | Get Alert |
| 04/13/2022 | GHRS | Buy Now | GH Research | $10.60 | 286.79% | Sumant Kulkarni42% | $45 → $41 | Maintains | Buy | Get Alert |
| 03/16/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 72.22% | Sumant Kulkarni42% | $30 → $31 | Upgrade | Hold → Buy | Get Alert |
| 03/14/2022 | CARA | Buy Now | Cara Therapeutics | $4.01 | 623.19% | Sumant Kulkarni42% | $396 → $348 | Maintains | Buy | Get Alert |
| 02/07/2022 | BIIB | Buy Now | Biogen | $143.09 | 113.15% | Sumant Kulkarni42% | $335 → $305 | Maintains | Buy | Get Alert |
| 01/28/2022 | CRTX | Buy Now | Cortexyme | — | — | Sumant Kulkarni42% | — | Downgrade | Buy → Hold | Get Alert |
| 12/22/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 66.67% | Sumant Kulkarni42% | $26 → $30 | Maintains | Hold | Get Alert |
| 09/16/2021 | CRTX | Buy Now | Cortexyme | — | — | Sumant Kulkarni42% | $75 → $150 | Maintains | Buy | Get Alert |
| 08/06/2021 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 0.74% | Sumant Kulkarni42% | $122 → $108 | Downgrade | Buy → Hold | Get Alert |
| 08/03/2021 | BHVN | Buy Now | Biohaven | $28.51 | 426.13% | Sumant Kulkarni42% | $101 → $150 | Maintains | Buy | Get Alert |
| 07/27/2021 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 1124.49% | Sumant Kulkarni42% | $119 → $96 | Maintains | Buy | Get Alert |
| 07/27/2021 | BIIB | Buy Now | Biogen | $143.09 | 195.62% | Sumant Kulkarni42% | $359 → $423 | Maintains | Buy | Get Alert |
| 07/20/2021 | GHRS | Buy Now | GH Research | $10.60 | 230.19% | Sumant Kulkarni42% | → $35 | Initiates | → Buy | Get Alert |
| 05/12/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 50% | Sumant Kulkarni42% | $26 → $27 | Maintains | Hold | Get Alert |
| 04/06/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 44.44% | Sumant Kulkarni42% | $40 → $26 | Downgrade | Buy → Hold | Get Alert |
| 04/01/2021 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 3942.55% | Sumant Kulkarni42% | $1760 → $1520 | Maintains | Buy | Get Alert |
| 03/09/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 122.22% | Sumant Kulkarni42% | $61 → $40 | Maintains | Buy | Get Alert |
| 11/16/2020 | BHVN | Buy Now | Biohaven | $28.51 | 285.83% | Sumant Kulkarni42% | $80 → $110 | Maintains | Buy | Get Alert |
| 11/12/2020 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 13.8% | Sumant Kulkarni42% | $145 → $122 | Maintains | Buy | Get Alert |
| 08/06/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 233.33% | Sumant Kulkarni42% | $56 → $60 | Maintains | Buy | Get Alert |
| 08/04/2020 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 35.25% | Sumant Kulkarni42% | $134 → $145 | Maintains | Buy | Get Alert |
| 06/10/2020 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 24.99% | Sumant Kulkarni42% | $123 → $134 | Maintains | Buy | Get Alert |
| 05/13/2020 | CRTX | Buy Now | Cortexyme | — | — | Sumant Kulkarni42% | $42 → $70 | Reiterates | → Buy | Get Alert |
| 05/07/2020 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 14.73% | Sumant Kulkarni42% | $122 → $123 | Maintains | Buy | Get Alert |
| 04/24/2020 | BIIB | Buy Now | Biogen | $143.09 | 144.6% | Sumant Kulkarni42% | $360 → $350 | Maintains | Buy | Get Alert |
| 04/08/2020 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 920.41% | Sumant Kulkarni42% | $96 → $80 | Maintains | Buy | Get Alert |
| 01/27/2020 | BIIB | Buy Now | Biogen | $143.09 | 151.59% | Sumant Kulkarni42% | → $360 | Upgrade | Hold → Buy | Get Alert |
| 11/05/2019 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 13.8% | Sumant Kulkarni42% | $120 → $122 | Maintains | Buy | Get Alert |
| 10/23/2019 | BIIB | Buy Now | Biogen | $143.09 | 113.15% | Sumant Kulkarni42% | $285 → $305 | Maintains | Hold | Get Alert |
| 09/17/2019 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Sumant Kulkarni42% | → $20 | Downgrade | Buy → Hold | Get Alert |
| 09/10/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | — | Sumant Kulkarni42% | — | Upgrade | Hold → Buy | Get Alert |
| 07/24/2019 | BIIB | Buy Now | Biogen | $143.09 | 99.18% | Sumant Kulkarni42% | $275 → $285 | Maintains | Hold | Get Alert |
| 06/03/2019 | CRTX | Buy Now | Cortexyme | — | — | Sumant Kulkarni42% | → $42 | Initiates | → Buy | Get Alert |
| 04/15/2019 | BHVN | Buy Now | Biohaven | $28.51 | 212.17% | Sumant Kulkarni42% | $46 → $89 | Maintains | Buy | Get Alert |
| 03/22/2019 | BIIB | Buy Now | Biogen | $143.09 | 92.19% | Sumant Kulkarni42% | $396 → $275 | Downgrade | Buy → Hold | Get Alert |
| 03/14/2019 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Sumant Kulkarni42% | $21 → $20 | Maintains | Buy | Get Alert |
| 12/10/2018 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 27.78% | Sumant Kulkarni42% | → $23 | Initiates | → Hold | Get Alert |
| 11/21/2018 | NBIX | Buy Now | Neurocrine Biosciences | $107.21 | 3.54% | Sumant Kulkarni42% | → $111 | Initiates | → Buy | Get Alert |
| 08/10/2018 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Sumant Kulkarni42% | $20 → $22 | Maintains | Buy | Get Alert |
| 07/23/2018 | BIIB | Buy Now | Biogen | $143.09 | 176.75% | Sumant Kulkarni42% | $335 → $396 | Maintains | Buy | Get Alert |
| 05/31/2018 | BIIB | Buy Now | Biogen | $143.09 | — | Sumant Kulkarni42% | — | Upgrade | Hold → Buy | Get Alert |
| 03/27/2018 | BHVN | Buy Now | Biohaven | $28.51 | 19.26% | Sumant Kulkarni42% | $39 → $34 | Maintains | Buy | Get Alert |
| 03/15/2018 | VYGR | Buy Now | Voyager Therapeutics | $3.88 | 800.9% | Sumant Kulkarni42% | $36 → $35 | Maintains | Buy | Get Alert |
| 02/28/2018 | AVXS | Buy Now | AveXis | — | — | Sumant Kulkarni42% | $110 → $120 | Maintains | Hold | Get Alert |
| 01/24/2018 | BIIB | Buy Now | Biogen | $143.09 | 144.6% | Sumant Kulkarni42% | $340 → $350 | Maintains | Hold | Get Alert |
| 10/27/2017 | VYGR | Buy Now | Voyager Therapeutics | $3.88 | 800.9% | Sumant Kulkarni42% | → $35 | Initiates | → Buy | Get Alert |
| 10/27/2017 | BIIB | Buy Now | Biogen | $143.09 | 137.61% | Sumant Kulkarni42% | → $340 | Initiates | → Hold | Get Alert |
| 10/27/2017 | AVXS | Buy Now | AveXis | — | — | Sumant Kulkarni42% | → $110 | Initiates | → Hold | Get Alert |
| 10/27/2017 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Sumant Kulkarni42% | → $20 | Initiates | → Buy | Get Alert |
| 01/31/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.39 | — | Sumant Kulkarni42% | — | Upgrade | Neutral → Buy | Get Alert |
| 11/07/2016 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.39 | — | Sumant Kulkarni42% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/01/2013 | BIIB | Buy Now | Biogen | $143.09 | 43.97% | Sumant Kulkarni42% | $200 → $206 | Maintains | Buy | Get Alert |
| 03/28/2013 | BIIB | Buy Now | Biogen | $143.09 | 39.77% | Sumant Kulkarni42% | $187 → $200 | Maintains | Buy | Get Alert |
| 02/27/2013 | BIIB | Buy Now | Biogen | $143.09 | 30.69% | Sumant Kulkarni42% | $163 → $187 | Upgrade | Hold → Buy | Get Alert |
| 01/03/2013 | BIIB | Buy Now | Biogen | $143.09 | -2.86% | Sumant Kulkarni42% | $144 → $139 | Maintains | Hold | Get Alert |
| 12/17/2012 | BIIB | Buy Now | Biogen | $143.09 | 0.64% | Sumant Kulkarni42% | → $144 | Initiates | → Hold | Get Alert |
